and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A, as Trustee Third Supplemental Indenture dated as of August 13, 2019 to Indenture dated as of September 9, 2014Third Supplemental Indenture • November 7th, 2019 • Assertio Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2019 Company Industry JurisdictionTHIRD SUPPLEMENTAL INDENTURE, dated as of August 13, 2019 (this “Supplemental Indenture”), between ASSERTIO THERAPEUTICS, INC., a Delaware corporation (the “Company”, as more fully set forth in Section 2.01), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a New York banking association, as trustee (the “Trustee,” as more fully set forth in Section 2.01), supplementing the Indenture relating to “Senior Debt Securities” dated as of September 9, 2014, between the Company and the Trustee (the “Base Indenture” and, as amended and supplemented by this Supplemental Indenture, and as it may be further amended or supplemented from time to time with respect to the Notes, the “Indenture”).
ASSERTIO THERAPEUTICS, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A, as Trustee Third Supplemental IndentureThird Supplemental Indenture • August 9th, 2019 • Assertio Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2019 Company Industry JurisdictionTHIRD SUPPLEMENTAL INDENTURE, dated as of August [·], 2019 (this “Supplemental Indenture”), between ASSERTIO THERAPEUTICS, INC., a Delaware corporation (the “Company”, as more fully set forth in Section 2.01), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a New York banking association, as trustee (the “Trustee,” as more fully set forth in Section 2.01), supplementing the Indenture relating to “Senior Debt Securities” dated as of September 9, 2014, between the Company and the Trustee (the “Base Indenture” and, as amended and supplemented by this Supplemental Indenture, and as it may be further amended or supplemented from time to time with respect to the Notes, the “Indenture”).
APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of October 5, 2018 to INDENTURE Dated as of March 17, 2014 5.375% Convertible Senior Notes due 2023Third Supplemental Indenture • October 5th, 2018 • Apollo Commercial Real Estate Finance, Inc. • Real estate investment trusts • New York
Contract Type FiledOctober 5th, 2018 Company Industry JurisdictionThis Third Supplemental Indenture, dated as of October 5, 2018 (this “Supplemental Indenture”), to the Indenture, dated as of March 17, 2014 (as amended, modified or supplemented from time to time in accordance therewith, the “Base Indenture” and, as amended, modified and supplemented by this Supplemental Indenture, the “Indenture”), between Apollo Commercial Real Estate Finance, Inc., a Maryland corporation, as issuer (the “Company,” subject to Section 1.01), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee,” subject to Section 1.01).
RESOURCE CAPITAL CORP. and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of August 16, 2017 to INDENTURE Dated as of October 21, 2013, 4.50% Convertible Senior Notes due 2022Third Supplemental Indenture • August 16th, 2017 • Resource Capital Corp. • Real estate investment trusts • New York
Contract Type FiledAugust 16th, 2017 Company Industry JurisdictionThis THIRD SUPPLEMENTAL INDENTURE, dated as of August 16, 2017 (the “Supplemental Indenture”), to the Indenture, dated as of October 21, 2013 (as amended, modified or supplemented from time to time in accordance therewith, the “Base Indenture” and, as amended, modified and supplemented by this Supplemental Indenture, the “Indenture”), between RESOURCE CAPITAL CORP., a Maryland corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).